Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined systemic and intratympanic steroid therapy in idiopathic sudden sensorineural hearing loss
2017-000658-20Phase 4Completed
- Start
- Feb 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexamethasone in idiopathic sudden sensorineural hearing loss (ISSNHL) (2 arms). Primary endpoint: Hearing recovery comparison between treatment groups. Started Feb 2017; status: completed.
02
Drugs
dexamethasone
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)
Beyond the preview
Go deeper on 2017-000658-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000658-20.